Propiedad y actividad de insiders de ProPhase Labs, Inc. (PRPH): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $0.01 |
| Capitalización | $0M |
| Bolsa | OTC |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2025-06-20 | Abenante Carolina | |||
| 2025-09-09 | Karkus Ted William | A-Award | 500,000 | $300K |
| 2025-02-17 | Hollenshead Stuart | A-Award | 500,000 | $300K |
| 2025-01-27 | Hollenshead Stuart | |||
| 2025-02-14 | Hirsch Warren | A-Award | 100,000 | $60K |
| 2025-02-14 | GLECKEL LOUIS MD | A-Award | 100,000 | $60K |
| 2024-03-17 | Karkus Ted William | A-Award | 400,000 | $2.4M |
| 2024-01-01 | Latkin Jed | A-Award | 500,000 | $3.0M |
| 2024-01-01 | Latkin Jed | |||
| 2024-03-17 | Hirsch Warren | A-Award | 70,000 | $420K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $441000 | $3.2M | $1.6M | $434000 | $6.8M | $8.7M | $9.1M | $1.6M | $678000 | $90000 |
| Inversiones a Corto | 0 | $18.8M | $6.7M | $926000 | $1.6M | $8.9M | $8.3M | $3.1M | 0 | 0 |
| Cuentas por Cobrar | $5.8M | $1.9M | $7.8M | $6.8M | $3.2M | $37.7M | $37.1M | $35.8M | $20.1M | $1.5M |
| Inventario | $2.7M | $1.5M | $1.9M | $1.5M | $3.0M | $4.6M | $4.0M | $2.3M | $1.1M | $70000 |
| Activos Corrientes | $9.6M | $28.9M | $18.2M | $9.9M | $15.9M | $61.3M | $60.8M | $47.6M | $30.6M | $3.1M |
| Inmovilizado Material | $3.2M | $2.7M | $2.5M | $2.3M | $8.3M | $10.3M | $11.3M | $14.9M | $11.6M | $2.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | $901000 | $5.7M | $5.7M | $5.2M | $5.2M | $4.0M |
| Activos Intangibles | 0 | 0 | 0 | 0 | $1.2M | $10.9M | $8.5M | $12.3M | $9.8M | $7.2M |
| Activos Totales | $12.8M | $34.2M | $20.7M | $12.3M | $31.4M | $89.3M | $87.6M | $91.9M | $63.2M | $59.9M |
| Cuentas por Pagar | $2.2M | $562000 | $437000 | $432000 | $3.8M | $7.0M | $5.9M | $8.6M | $13.7M | $13.0M |
| Deuda a Corto | $1.5M | 0 | 0 | 0 | $329000 | $663000 | $301000 | $2.8M | $6.6M | $5.2M |
| Pasivos Corrientes | $6.8M | $1.8M | $4.2M | $933000 | $6.3M | $15.5M | $16.1M | $20.9M | $32.1M | $53.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $10.0M | $10.0M | $2.4M | $7.3M | $11.7M | 0 |
| Pasivos Totales | $6.8M | $1.1M | $4.2M | $1.0M | $20.8M | $30.7M | $24.0M | $42.5M | $55.8M | $56.4M |
| Reservas | -$19.7M | $22.1M | $4.5M | -$1.5M | -$3.6M | $2.6M | $11.8M | -$5.0M | -$58.4M | -$73.1M |
| Patrimonio Neto | $6.0M | $31.8M | $16.5M | $11.2M | $10.6M | $58.6M | $63.6M | $49.4M | $7.4M | $3.5M |
| Deuda Total | $1.5M | 0 | 0 | 0 | $14.7M | $14.9M | $7.0M | $18.5M | $24.6M | $8.6M |
| Deuda Neta | $1.0M | -$21.9M | -$8.2M | -$1.4M | $6.3M | -$2.6M | -$10.5M | $13.7M | $23.9M | $8.5M |
| Capital Circulante | $2.8M | $27.1M | $14.0M | $9.0M | $9.6M | $45.8M | $44.8M | $26.7M | -$1.5M | -$49.9M |
Salud financiera
| Deuda / Patrimonio | -2.93 |
| Ratio corriente | 0.05 |
Rentabilidad
| Rentabilidad sobre capital | -1358.66% |
| Rentabilidad sobre capital invertido | -188.35% |
| Rentabilidad sobre activos | -39.44% |
| Margen bruto | 16.38% |
| Margen operativo | -498.73% |
| Margen neto | -717.43% |
Empresas relacionadas: ADAP · AEMD · ALUR · AYTU · BFRI · CODX · ERNA
Explorar sector: Healthcare · Medical - Pharmaceuticals
Más secciones de PRPH: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones